Payment overview · 2025
General Payments
$35.34
2 reported records · 1 companies
Healthcare provider profile · identity verified
Michele Morandi, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · ROSELLE PARK, NJ · NPI 1033186739
Verified facts
What the public records show
CMS Open Payments records show Michele Morandi, D.O. received $35.34 in general payments during 2025 across 2 reported records.
Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 104 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 44 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $35.34 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.34 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $35.34 | 2 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $35.34 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
104 | 17 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
44 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 967 | 176 |
| Amlodipine Besylate | Amlodipine Besylate | 900 | 167 |
| Levothyroxine Sodium | Levothyroxine Sodium | 699 | 108 |
| Eliquis | Apixaban | 660 | 83 |
| Metoprolol Succinate | Metoprolol Succinate | 614 | 83 |
| Gabapentin | Gabapentin | 520 | 70 |
| Tamsulosin Hcl | Tamsulosin Hcl | 470 | 67 |
| Famotidine | Famotidine | 464 | 42 |
| Quetiapine Fumarate | Quetiapine Fumarate | 446 | 42 |
| Metformin Hcl | Metformin Hcl | 418 | 72 |
| Mirtazapine | Mirtazapine | 407 | 48 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 381 | 74 |
| Escitalopram Oxalate | Escitalopram Oxalate | 375 | 46 |
| Metoprolol Tartrate | Metoprolol Tartrate | 375 | 72 |
| Clopidogrel | Clopidogrel Bisulfate | 371 | 53 |
| Sertraline Hcl | Sertraline Hcl | 348 | 38 |
| Divalproex Sodium | Divalproex Sodium | 335 | 46 |
| Pantoprazole Sodium | Pantoprazole Sodium | 330 | 89 |
| Carvedilol | Carvedilol | 322 | 53 |
| Losartan Potassium | Losartan Potassium | 297 | 56 |
| Trazodone Hcl | Trazodone Hcl | 292 | 33 |
| Donepezil Hcl | Donepezil Hcl | 269 | 29 |
| Furosemide | Furosemide | 255 | 50 |
| Risperidone | Risperidone | 248 | 18 |
| Lisinopril | Lisinopril | 241 | 40 |
| Simvastatin | Simvastatin | 229 | 45 |
| Levetiracetam | Levetiracetam | 183 | 17 |
| Latanoprost | Latanoprost | 168 | 30 |
| Olanzapine | Olanzapine | 168 | 12 |
| Xarelto | Rivaroxaban | 159 | 13 |
| Montelukast Sodium | Montelukast Sodium | 157 | 20 |
| Januvia | Sitagliptin Phosphate | 151 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 147 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 147 | 16 |
| Potassium Chloride | Potassium Chloride | 146 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 144 | 28 |
| Spironolactone | Spironolactone | 137 | 20 |
| Memantine Hcl | Memantine Hcl | 136 | 18 |
| Nifedipine Er | Nifedipine | 123 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 118 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 117 | 38 |
| Benztropine Mesylate | Benztropine Mesylate | 115 | 12 |
| Glimepiride | Glimepiride | 114 | 14 |
| Buspirone Hcl | Buspirone Hcl | 107 | 16 |
| Hydrochlorothiazide | Hydrochlorothiazide | 106 | 23 |
| Jardiance | Empagliflozin | 104 | 17 |
| Omeprazole | Omeprazole | 102 | 23 |
| Valsartan | Valsartan | 101 | 30 |
| Bupropion Xl | Bupropion Hcl | 100 | suppressed |
| Torsemide | Torsemide | 99 | 22 |
| Midodrine Hcl | Midodrine Hcl | 98 | 24 |
| Allopurinol | Allopurinol | 89 | 29 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 81 | 23 |
| Ezetimibe | Ezetimibe | 80 | 19 |
| Finasteride | Finasteride | 80 | 14 |
| Meloxicam | Meloxicam | 79 | 17 |
| Scopolamine | Scopolamine | 76 | suppressed |
| Prednisone | Prednisone | 75 | 15 |
| Lamotrigine | Lamotrigine | 73 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 73 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 73 | suppressed |
| Carbamazepine | Carbamazepine | 71 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 70 | 11 |
| Vascepa | Icosapent Ethyl | 69 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 67 | 12 |
| Metformin Hcl Er | Metformin Hcl | 66 | suppressed |
| Sucralfate | Sucralfate | 65 | 11 |
| Alendronate Sodium | Alendronate Sodium | 64 | 13 |
| Baclofen | Baclofen | 62 | 13 |
| Carbamazepine Er | Carbamazepine | 62 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 62 | 12 |
| Nystatin | Nystatin | 62 | 30 |
| Citalopram Hbr | Citalopram Hydrobromide | 60 | suppressed |
| Lactulose | Lactulose | 59 | 15 |
| Methenamine Hippurate | Methenamine Hippurate | 59 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 57 | 21 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 57 | 31 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 56 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 54 | suppressed |
| Dutasteride | Dutasteride | 53 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 53 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 52 | suppressed |
| Thiothixene | Thiothixene | 51 | suppressed |
| Alprazolam | Alprazolam | 50 | 24 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 49 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 48 | suppressed |
| Aripiprazole | Aripiprazole | 47 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 47 | 32 |
| Glipizide | Glipizide | 46 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 46 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 44 | suppressed |
| Mupirocin | Mupirocin | 44 | 22 |
| Tradjenta | Linagliptin | 44 | suppressed |
| Trulicity | Dulaglutide | 44 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 43 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 42 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 42 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Lidocaine | Lidocaine | 42 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 42 | suppressed |
| Calcium Acetate | Calcium Acetate | 39 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 39 | suppressed |
| Dexamethasone | Dexamethasone | 38 | suppressed |
| Insulin Lispro | Insulin Lispro | 38 | 18 |
| Multaq | Dronedarone Hcl | 37 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 15 |
| Procrit | Epoetin Alfa | 37 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 36 | suppressed |
| Droxidopa | Droxidopa | 36 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 36 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 36 | suppressed |
| Timolol Maleate | Timolol Maleate | 36 | suppressed |
| Nyamyc | Nystatin | 35 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 35 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 34 | suppressed |
| Repaglinide | Repaglinide | 34 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 33 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 33 | suppressed |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 32 | suppressed |
| Ozempic | Semaglutide | 31 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 31 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 31 | suppressed |
| Rytary | Carbidopa/Levodopa | 31 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 31 | suppressed |
| Xifaxan | Rifaximin | 31 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 30 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Ketoconazole | Ketoconazole | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 29 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 29 | suppressed |
| Hydrocortisone | Hydrocortisone | 29 | 14 |
| Lacosamide | Lacosamide | 29 | suppressed |
| Clozapine | Clozapine | 28 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 27 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 27 | suppressed |
| Topiramate | Topiramate | 27 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 26 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 26 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 26 | suppressed |
| Cyclosporine | Cyclosporine | 25 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 25 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 25 | suppressed |
| Zanaflex | Tizanidine Hcl | 25 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 24 | 24 |
| Atenolol | Atenolol | 24 | suppressed |
| Brilinta | Ticagrelor | 24 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Alogliptin | Alogliptin Benzoate | 22 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 22 | suppressed |
| Cephalexin | Cephalexin | 22 | 11 |
| Ibandronate Sodium | Ibandronate Sodium | 22 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 22 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 22 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 21 | 11 |
| Dorzolamide Hcl | Dorzolamide Hcl | 21 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | suppressed |
| Synthroid | Levothyroxine Sodium | 21 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 20 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 13 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 19 | suppressed |
| Naproxen | Naproxen | 19 | 11 |
| Venlafaxine Hcl | Venlafaxine Hcl | 19 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 19 | suppressed |
| Amantadine | Amantadine Hcl | 18 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 18 | 11 |
| Fiasp | Insulin Aspart (Niacinamide) | 18 | suppressed |
| Humalog | Insulin Lispro | 18 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 18 | suppressed |
| Restasis | Cyclosporine | 18 | suppressed |
| Risperidone Er | Risperidone Microspheres | 18 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 18 | 11 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | suppressed |
| Azithromycin | Azithromycin | 16 | 16 |
| Clonazepam | Clonazepam | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Prograf | Tacrolimus | 16 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 15 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 15 | suppressed |
| Admelog | Insulin Lispro | 14 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 14 | suppressed |
| Cholestyramine Light | Cholestyramine | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Lorazepam | Lorazepam | 14 | suppressed |
| Lumigan | Bimatoprost | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Nystop | Nystatin | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Perphenazine | Perphenazine | 13 | suppressed |
| Travoprost | Travoprost | 13 | suppressed |
| Brinzolamide | Brinzolamide | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Methazolamide | Methazolamide | 12 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.34 · 2 records | Lilly USA, LLC | MOUNJARO, ZEPBOUND | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error